Otherwise, a remarkable and statistically significant difference in OS was detected between the two groups of patients that displayed different concentrations of CD133 + CD326− EVs in the whole cancer population (HR 2.79; 95% CI 1.51–5.17, p=0.001; Supplementary /Figure 2). The gene discussed is PROM1; the disease is cancer.